Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Description

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

Conditions

Human Papillomavirus

Talk to us

Study Overview

On this page

Study Details

Study overview

To learn if new HPV tests can provide the same results as standard HPV tests. The findings from this study may aid in the development of new HPV tests that require less equipment and are more accessible.

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)

Condition
Human Papillomavirus
Intervention / Treatment

-

Contacts and Locations

Houston

MD Anderson Cancer Center, Houston, Texas, United States, 77030

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. People with a cervix 21 years of age or older.
  • 2. Scheduled to undergo hrHPV testing at MD Anderson and The Harris Health System (LBJ Hospital) according to national and institutional guidelines at time of enrollment OR are anticipated to undergo a LEEP, ECC, or biopsy.
  • 3. Willing and able to provide informed consent.
  • 4. Able to perform protocol-required activities. Able to speak and read English or Spanish.
  • 1. Patient or provider decision not to perform HPV testing. This does not apply to patients that are undergoing either a LEEP, ECC or biopsy.
  • 2. Participant or provider decision not to collect a sample for this study.
  • 3. Participants that are pregnant.

Ages Eligible for Study

21 Years to

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

M.D. Anderson Cancer Center,

Kathleen Schmeler, MD, PRINCIPAL_INVESTIGATOR, M.D. Anderson Cancer Center

Study Record Dates

2028-03-31